NCT04023760View on ClinicalTrials.gov

Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
PharmacokineticsKidney TransplantLung Transplant
Interventions
DRUG

Apixaban

Study subjects given a single-dose of apixaban 10 mg.

Trial Locations (1)

Unknown

Saskatchewan Health Authority, Saskatoon

All Listed Sponsors
collaborator

Saskatchewan Health Research Foundation

OTHER

collaborator

Lung Association of Saskatchewan

UNKNOWN

lead

University of Saskatchewan

OTHER

NCT04023760 - Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients | Biotech Hunter | Biotech Hunter